Disclosures for "Early Real-life Experience on Zilucoplan for Generalized Myasthenia Gravis: ZILU25 Multicenter Observational Study"
-
Dr. Di Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
-
Dr. Rini has nothing to disclose.
-
The institution of Dr. Alboini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Alboini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Alboini has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Alexion.
-
Alvino Bisecco has nothing to disclose.
-
Valentina Damato has nothing to disclose.
-
Dr. Fionda has nothing to disclose.
-
Francesco Habetswallner has nothing to disclose.
-
Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Therapeutics. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson.
-
Dr. Maestri Tassoni has received personal compensation for serving as an employee of Alexion. Dr. Maestri Tassoni has received personal compensation for serving as an employee of Argenx. Dr. Maestri Tassoni has received personal compensation for serving as an employee of Ucb. Dr. Maestri Tassoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Maestri Tassoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Maestri Tassoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ucb. Dr. Maestri Tassoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Maestri Tassoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Maestri Tassoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb.
-
Dr. Pugliese has nothing to disclose.
-
Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
-
Dr. VINCIGUERRA has received personal compensation in the range of $0-$499 for serving as a speakers, manuscript writing, and educational events with Alexion.
-
Dr. FRANGIAMORE has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB PHARMA. Dr. FRANGIAMORE has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. Dr. FRANGIAMORE has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. FRANGIAMORE has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB PHARMA.